Federal contract award

75F40123P00030

FDA-RFQ-CFSAN-2023-116452 SS TO PURCHASE SERVICE CONTRACT TO COVER THE REPAIR AND MAINTENANCE OF 7 ILLUMINA MISEQ INSTRUMENTS OWNED BY FDA/CFSAN, PLUS FOUR (4) OPTION YEARS OF PREVENTATIVE MAINTENANCE AGREEMENT (PMA)

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeFDA OFFICE OF ACQ GRANT SVCS
NAICS811210 — Electronic and Precision Equipment Repair and Maintenance
PSCJ066 — Maintenance, Repair and Rebuilding of Equipment: Instruments and Laboratory Equipment
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$332.6K
Current contract value$332.6K
Potential contract value / ceiling$422.7K
Start dateJan 29, 2023
Current end dateDec 30, 2026
Potential end dateDec 30, 2027
Latest award activityDec 31, 2025
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Dec 31, 2025P00005$85.9KFDA-RFQ-CFSAN-2023-116452 SS TO PURCHASE SERVICE CONTRACT TO COVER THE REPAIR AND MAINTENANCE OF 7 ILLUMINA MISEQ INSTRUMENTS OWNED BY FDA/CFSAN, PLUS FOUR (4) OPTION YEARS OF PREVENTATIVE MAINTENANCE AGREEMENT (PMA)
Mar 10, 2025P00004$0FDA-RFQ-CFSAN-2023-116452 SS TO PURCHASE SERVICE CONTRACT TO COVER THE REPAIR AND MAINTENANCE OF 7 ILLUMINA MISEQ INSTRUMENTS OWNED BY FDA/CFSAN, PLUS FOUR (4) OPTION YEARS OF PREVENTATIVE MAINTENANCE AGREEMENT (PMA)
Dec 26, 2024P00003$78.0KFDA-RFQ-CFSAN-2023-116452 SS TO PURCHASE SERVICE CONTRACT TO COVER THE REPAIR AND MAINTENANCE OF 7 ILLUMINA MISEQ INSTRUMENTS OWNED BY FDA/CFSAN, PLUS FOUR (4) OPTION YEARS OF PREVENTATIVE MAINTENANCE AGREEMENT (PMA)
Dec 28, 2023P00002$77.9KFDA-RFQ-CFSAN-2023-116452 SS TO PURCHASE SERVICE CONTRACT TO COVER THE REPAIR AND MAINTENANCE OF 7 ILLUMINA MISEQ INSTRUMENTS OWNED BY FDA/CFSAN, PLUS FOUR (4) OPTION YEARS OF PREVENTATIVE MAINTENANCE AGREEMENT (PMA)
Feb 2, 2023P00001$0FDA-RFQ-CFSAN-2023-116452 SS TO PURCHASE SERVICE CONTRACT TO COVER THE REPAIR AND MAINTENANCE OF 7 ILLUMINA MISEQ INSTRUMENTS OWNED BY FDA/CFSAN, PLUS FOUR (4) OPTION YEARS OF PREVENTATIVE MAINTENANCE AGREEMENT (PMA)
Jan 29, 20230$90.9KFDA-RFQ-CFSAN-2023-116452 SS TO PURCHASE SERVICE CONTRACT TO COVER THE REPAIR AND MAINTENANCE OF 7 ILLUMINA MISEQ INSTRUMENTS OWNED BY FDA/CFSAN, PLUS FOUR (4) OPTION YEARS OF PREVENTATIVE MAINTENANCE AGREEMENT (PMA)

Estimated positioning window

Dec 30, 2026 – Jun 30, 2027

Recompete signal:
70/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 70/100. Available recorded signals: 65 points.

Contract end 2027-12-30 (424 days from calculation)
+25 points
170 historical awards in this buyer and category group
+15 points
6 recorded award transactions
+10 points
Latest award action: 2025-12-31
+5 points
Parent award identifier recorded
+0 points
Solicitation identifier recorded
+10 points
Linked official forecast
+0 points
Calculated on
2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Verify whether remaining options may extend performance beyond the current end date.
  3. Check the stated set-aside against the solicitation and current certifications.
  4. Review the award scope and buyer evidence before making a bid/no-bid decision.